BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31069006)

  • 1. Prediction of onset of remnant gastric cancer by promoter DNA methylation of
    Kojima K; Minatani N; Ushiku H; Ishii S; Tanaka T; Yokoi K; Nishizawa N; Ooizumi Y; Igarashi K; Hosoda K; Moriya H; Mieno H; Watanabe M; Yamashita K
    Oncotarget; 2019 Mar; 10(25):2423-2434. PubMed ID: 31069006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Prognostic Relevance of Promoter DNA Methylation of
    Tanaka Y; Kosaka Y; Waraya M; Yokota K; Harada H; Kaida T; Kikuchi M; Minatani N; Nishimiya H; Katoh H; Sengoku N; Watanabe M; Yamashita K
    Anticancer Res; 2019 May; 39(5):2289-2298. PubMed ID: 31092420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of promoter DNA hypermethylation of the cysteine dioxygenase 1 (CDO1) gene in primary gallbladder cancer and gallbladder disease.
    Igarashi K; Yamashita K; Katoh H; Kojima K; Ooizumi Y; Nishizawa N; Nishiyama R; Kawamata H; Tajima H; Kaizu T; Kumamoto Y; Watanabe M
    PLoS One; 2017; 12(11):e0188178. PubMed ID: 29161283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the methylation of CpG islands in the
    Maekawa H; Ito T; Orita H; Kushida T; Sakurada M; Sato K; Hulbert A; Brock MV
    Oncol Lett; 2020 Mar; 19(3):2197-2204. PubMed ID: 32194717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive Significance of Promoter DNA Methylation of
    Kubota Y; Tanabe S; Azuma M; Horio K; Fujiyama Y; Soeno T; Furue Y; Wada T; Watanabe A; Ishido K; Katada C; Yamashita K; Koizumi W; Kusano C
    J Gastric Cancer; 2021 Dec; 21(4):379-391. PubMed ID: 35079440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic potential of hypermethylation of the cysteine dioxygenase 1 gene (CDO1) promoter DNA in pancreatic cancer.
    Nishizawa N; Harada H; Kumamoto Y; Kaizu T; Katoh H; Tajima H; Ushiku H; Yokoi K; Igarashi K; Fujiyama Y; Okuwaki K; Iwai T; Watanabe M; Yamashita K
    Cancer Sci; 2019 Sep; 110(9):2846-2855. PubMed ID: 31325200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter hypermethylation of cysteine dioxygenase type 1 in patients with non-small cell lung cancer.
    Yin W; Wang X; Li Y; Wang B; Song M; Hulbert A; Chen C; Yu F
    Oncol Lett; 2020 Jul; 20(1):967-973. PubMed ID: 32566027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of Efficacy of Postoperative Chemotherapy by DNA Methylation of CDO1 in Gastric Cancer.
    Harada H; Soeno T; Yokoi K; Nishizawa N; Ushiku H; Hosoda K; Hiki N; Yamashita K
    J Surg Res; 2020 Dec; 256():404-412. PubMed ID: 32777557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-specific promoter DNA methylation of Cysteine dioxygenase type 1 (CDO1) gene as an important prognostic biomarker of gastric cancer.
    Harada H; Hosoda K; Moriya H; Mieno H; Ema A; Ushiku H; Washio M; Nishizawa N; Ishii S; Yokota K; Tanaka Y; Kaida T; Soeno T; Kosaka Y; Watanabe M; Yamashita K
    PLoS One; 2019; 14(4):e0214872. PubMed ID: 30934021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of cancer specific methylation of the CDO1 gene in small bowel cancer.
    Kojima K; Nakamura T; Ooizumi Y; Igarashi K; Tanaka T; Yokoi K; Ishii S; Nishizawa N; Katoh H; Kosaka Y; Sato T; Watanabe M; Yamashita K
    PLoS One; 2019; 14(1):e0211108. PubMed ID: 30677088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Significance of Promoter DNA Hypermethylation of cysteine dioxygenase 1 (CDO1) Gene in Primary Breast Cancer.
    Minatani N; Waraya M; Yamashita K; Kikuchi M; Ushiku H; Kojo K; Ema A; Nishimiya H; Kosaka Y; Katoh H; Sengoku N; Tanino H; Sidransky D; Watanabe M
    PLoS One; 2016; 11(1):e0144862. PubMed ID: 26785325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status in remnant gastric cancer after distal gastrectomy.
    Ohira M; Toyokawa T; Sakurai K; Kubo N; Tanaka H; Muguruma K; Yashiro M; Onoda N; Hirakawa K
    World J Gastroenterol; 2016 Feb; 22(8):2424-33. PubMed ID: 26937131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reprimo as a potential biomarker for early detection in gastric cancer.
    Bernal C; Aguayo F; Villarroel C; Vargas M; Díaz I; Ossandon FJ; Santibáñez E; Palma M; Aravena E; Barrientos C; Corvalan AH
    Clin Cancer Res; 2008 Oct; 14(19):6264-9. PubMed ID: 18829507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA diagnosis of peritoneal fluid cytology test by CDO1 promoter DNA hypermethylation in gastric cancer.
    Ushiku H; Yamashita K; Ema A; Minatani N; Kikuchi M; Kojo K; Yokoi K; Tanaka T; Nishizawa N; Ishii S; Hosoda K; Moriya H; Mieno H; Katada N; Kikuchi S; Katoh H; Watanabe M
    Gastric Cancer; 2017 Sep; 20(5):784-792. PubMed ID: 28243814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation genome-wide analysis in remnant and primary gastric cancers.
    Sugimoto K; Ito T; Hulbert A; Chen C; Orita H; Maeda M; Moro H; Fukagawa T; Ushijima T; Katai H; Wada R; Sato K; Sakamoto K; Yu W; Considine M; Cope L; Brock MV
    Gastric Cancer; 2019 Nov; 22(6):1109-1120. PubMed ID: 30863929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implication of Reprimo and hMLH1 gene methylation in early diagnosis of gastric carcinoma.
    Liu L; Yang X
    Int J Clin Exp Pathol; 2015; 8(11):14977-82. PubMed ID: 26823831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical significance of cysteine dioxygenase type 1 methylation in Barrett esophagus adenocarcinoma.
    Kojima K; Yamashita K; Ushiku H; Katoh H; Ishii S; Tanaka T; Yokoi K; Suzuki M; Ooizumi Y; Igarashi K; Hosoda K; Moriya H; Mieno H; Katada N; Tanabe S; Watanabe M
    Dis Esophagus; 2017 Mar; 30(3):1-9. PubMed ID: 28184414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylated promoter DNA of CDO1 gene and preoperative serum CA19-9 are prognostic biomarkers in primary extrahepatic cholangiocarcinoma.
    Nakamoto S; Kumamoto Y; Igarashi K; Fujiyama Y; Nishizawa N; Ei S; Tajima H; Kaizu T; Watanabe M; Yamashita K
    PLoS One; 2018; 13(10):e0205864. PubMed ID: 30325974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypermethylated
    Wang L; Dong L; Xu J; Guo L; Wang Y; Wan K; Jing W; Zhao L; Feng X; Zhang K; Guo M; Zou Y; Zhang L; Li Q
    Front Oncol; 2022; 12():714663. PubMed ID: 35574348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential utility of HOP homeobox gene promoter methylation as a marker of tumor aggressiveness in gastric cancer.
    Ooki A; Yamashita K; Kikuchi S; Sakuramoto S; Katada N; Kokubo K; Kobayashi H; Kim MS; Sidransky D; Watanabe M
    Oncogene; 2010 Jun; 29(22):3263-75. PubMed ID: 20228841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.